What the six lenses say about HIKAL — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.
How HIKAL’s own sector index is moving — context for reading the stock’s six lenses.
Six-lens read
The actual numbers
The actual numbers
Full 8-quarter history in the financials table below.
The actual numbers
The actual numbers
Every filing in the corporate-announcements panel below.
The actual numbers
Decile — each lens’s 0–100 score is ranked against every Micro-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.
Conviction — the average of the two active conviction-lens deciles (Technical & Flow):
Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.
Glass box
Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.
Policy
Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.
PLI Scheme — Pharmaceuticals & API
Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices
Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.
| Baseline | 1D | 1W | 1M | 3M | 6M | 12M |
|---|---|---|---|---|---|---|
Nifty 50 Large-cap anchor | +9.8pp | +21.9pp | +13.2pp | +32.3pp | +36.6pp | -2.4pp |
Nifty 500 Broad-market baseline | +9.7pp | +21.9pp | +12.2pp | +30.7pp | +30.8pp | -7.6pp |
Sector Own-sector index | — | — | +9.3pp | +24.7pp | +17.7pp | -28.4pp |
From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).
Trend
HIKAL daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.
Relative strength
HIKAL ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.
TradingView composite technical analysis — multi-timeframe consensus
Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.
| Metric | Jun '24 | Sep '24 | Dec '24 | Mar '25 | Jun '25 | Sep '25 | Dec '25 | Mar '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue (₹cr) | 407 | 453 | 448 | 552 | 380 | 318 | 494 | 519 |
| ↳ change QoQ | — | +11.3% | -1.1% | +23.3% | -31.2% | -16.3% | +55.3% | +5.1% |
| EBITDA (₹cr) | 59 | 75 | 76 | 123 | 25 | 7 | 83 | 105 |
| EBITDA margin | 14.4% | 16.6% | 16.9% | 22.3% | 6.6% | 2.2% | 16.8% | 20.2% |
| PAT (₹cr) | 5 | 18 | 17 | 50 | -22 | -35 | -6 | 14 |
| ↳ change QoQ | — | +258.8% | -6.0% | +190.7% | -144.0% | -59.1% | +82.9% | +333.3% |
| Net margin | 1.3% | 4.0% | 3.8% | 9.1% | -5.8% | -11.0% | -1.2% | 2.7% |
| EPS (₹) | 0.41 | 1.48 | 1.39 | 4.07 | -1.82 | -2.83 | -0.48 | 1.17 |
| D/E | — | — | — | — | — | — | — | — |
Filings to the exchange — capital actions, earnings and governance. Most recent first.
A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗…and 5 more.
Ownership
Mutual funds holding HIKAL (2)
| Fund | Weight | AUM ₹cr | Grade |
|---|---|---|---|
| Tata Small Cap Fund Reg Gr | 0.58% | 12,696 | |
| ICICI Pru Pharma Healthcare Diag Gr | 1.18% | 6,803 |
ETFs holding HIKAL (0)
No tracked ETF holds HIKAL ≥0.5%.